Follow
Ricard Ferrer
Ricard Ferrer
Intensive Care Department. Hospital Universitari Vall d’Hebron.
Verified email at vallhebron.cat
Title
Cited by
Cited by
Year
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016
A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ...
Intensive care medicine 43, 304-377, 2017
102422017
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
L Evans, A Rhodes, W Alhazzani, M Antonelli, CM Coopersmith, C French, ...
Critical care medicine 49 (11), e1063-e1143, 2021
34782021
Genomewide association study of severe Covid-19 with respiratory failure
D Ellinghaus, F Degenhardt, L Bujanda, M Buti, A Albillos, P Invernizzi, ...
The New England journal of medicine, 2020
1834*2020
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program
R Ferrer, I Martin-Loeches, G Phillips, TM Osborn, S Townsend, ...
Critical care medicine 42 (8), 1749-1755, 2014
16172014
Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain
R Ferrer, A Artigas, MM Levy, J Blanco, G Gonzalez-Diaz, ...
Jama 299 (19), 2294-2303, 2008
9442008
Cristaloides y coloides en la reanimación del paciente crítico
J Garnacho-Montero, E Fernández-Mondéjar, R Ferrer-Roca, ...
Medicina intensiva 39 (5), 303-315, 2015
8432015
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7002021
Fluid challenges in intensive care: the FENICE study: a global inception cohort study
M Cecconi, C Hofer, JL Teboul, V Pettila, E Wilkman, Z Molnar, ...
Intensive care medicine 41, 1529-1537, 2015
6102015
Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study
R Ferrer, A Artigas, D Suarez, E Palencia, MM Levy, A Arenzana, ...
American journal of respiratory and critical care medicine 180 (9), 861-866, 2009
5552009
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a …
M Bassetti, R Echols, Y Matsunaga, M Ariyasu, Y Doi, R Ferrer, TP Lodise, ...
The Lancet infectious diseases 21 (2), 226-240, 2021
4872021
The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study)
A Rhodes, G Phillips, R Beale, M Cecconi, JD Chiche, D De Backer, ...
Intensive care medicine 41, 1620-1628, 2015
4722015
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, ...
The Lancet Respiratory Medicine 9 (6), 622-642, 2021
4712021
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
4222021
Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak
E Azoulay, J De Waele, R Ferrer, T Staudinger, M Borkowska, P Povoa, ...
Annals of intensive care 10, 1-8, 2020
3792020
Surviving sepsis campaign: research priorities for sepsis and septic shock
CM Coopersmith, D De Backer, CS Deutschman, R Ferrer, I Lat, ...
Intensive care medicine 44, 1400-1426, 2018
3332018
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3162021
Ventilator-associated pneumonia: incidence, risk factors, and microbiology.
TT Bauer, R Ferrer, J Angrill, G Schultze-Werninghaus, A Torres
Seminars in respiratory infections 15 (4), 272-279, 2000
3052000
Albumin administration in the acutely ill: what is new and where next?
JL Vincent, JA Russell, M Jacob, G Martin, B Guidet, J Wernerman, ...
Critical Care 18, 1-10, 2014
2692014
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use
P Schuetz, A Beishuizen, M Broyles, R Ferrer, G Gavazzi, EH Gluck, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 57 (9), 1308-1318, 2019
2562019
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ...
The Lancet Respiratory Medicine 9 (5), 522-532, 2021
2522021
The system can't perform the operation now. Try again later.
Articles 1–20